Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Artículo en Inglés | MEDLINE | ID: mdl-30742862

RESUMEN

Exposure of rats to an environment with low O2 levels evokes a panic-like escape behavior and recruits the dorsal periaqueductal gray (dPAG), which is considered to be a key region in the pathophysiology of panic disorder. The neurochemical basis of this response is, however, currently unknown. We here investigated the role played by nitric oxide (NO) within the dPAG in mediation of the escape reaction induced by hypoxia exposure. The results showed that exposure of male Wistar rats to 7% O2 increased nitrite levels, a NO metabolite, in the dPAG but not in the amygdala or hypothalamus. Nitrite levels in the dPAG were correlated with the number of escape attempts during the hypoxia challenge. Injections of the NO synthesis inhibitor NPA, the NO-scavenger c- PTIO, or the NMDA receptor antagonist AP-7 into the dorsolateral column of the periaqueductal gray (dlPAG) inhibited escape expression during hypoxia, without affecting the rats' locomotion. Intra-dlPAG administration of c-PTIO had no effect on the escape response evoked by the elevated-T maze, a defensive behavior that has also been associated with panic attacks. Altogether, our results suggest that NO plays a critical role in mediation of the panic-like defensive response evoked by exposure to low O2 concentrations.


Asunto(s)
Reacción de Fuga/fisiología , Hipoxia/fisiopatología , Óxido Nítrico/fisiología , Pánico/fisiología , Sustancia Gris Periacueductal/fisiología , 2-Amino-5-fosfonovalerato/administración & dosificación , 2-Amino-5-fosfonovalerato/análogos & derivados , 2-Amino-5-fosfonovalerato/farmacología , Amígdala del Cerebelo/metabolismo , Animales , Arginina/administración & dosificación , Arginina/análogos & derivados , Arginina/farmacología , Reacción de Fuga/efectos de los fármacos , Hipotálamo/metabolismo , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Microinyecciones , Actividad Motora/efectos de los fármacos , Nitritos/metabolismo , Sustancia Gris Periacueductal/metabolismo , Ratas
2.
J Psychopharmacol ; 31(6): 715-721, 2017 06.
Artículo en Inglés | MEDLINE | ID: mdl-28583050

RESUMEN

The dorsomedial hypothalamus (DMH) and the dorsal periaqueductal gray (DPAG) have been implicated in the genesis and regulation of panic-related defensive behaviors, such as escape. Previous results point to an interaction between serotonergic and opioidergic systems within the DPAG to inhibit escape, involving µ-opioid and 5-HT1A receptors (5-HT1AR). In the present study we explore this interaction in the DMH, using escape elicited by electrical stimulation of this area as a panic attack index. The obtained results show that intra-DMH administration of the non-selective opioid receptor antagonist naloxone (0.5 nmol) prevented the panicolytic-like effect of a local injection of serotonin (20 nmol). Pretreatment with the selective µ-opioid receptor (MOR) antagonist CTOP (1 nmol) blocked the panicolytic-like effect of the 5-HT1AR agonist 8-OHDPAT (8 nmol). Intra-DMH injection of the selective MOR agonist DAMGO (0.3 nmol) also inhibited escape behavior, and a previous injection of the 5-HT1AR antagonist WAY-100635 (0.37 nmol) counteracted this panicolytic-like effect. These results offer the first evidence that serotonergic and opioidergic systems work together within the DMH to inhibit panic-like behavior through an interaction between µ-opioid and 5-HT1A receptors, as previously described in the DPAG.


Asunto(s)
Hipotálamo/metabolismo , Trastorno de Pánico/metabolismo , Pánico/fisiología , Receptor de Serotonina 5-HT1A/metabolismo , Receptores Opioides mu/metabolismo , 8-Hidroxi-2-(di-n-propilamino)tetralin/farmacología , Analgésicos Opioides/farmacología , Animales , Encefalina Ala(2)-MeFe(4)-Gli(5)/farmacología , Reacción de Fuga/efectos de los fármacos , Reacción de Fuga/fisiología , Hipotálamo/efectos de los fármacos , Masculino , Naloxona/farmacología , Pánico/efectos de los fármacos , Sustancia Gris Periacueductal/efectos de los fármacos , Sustancia Gris Periacueductal/metabolismo , Piperazinas/farmacología , Piridinas/farmacología , Ratas , Ratas Wistar , Serotonina/farmacología , Somatostatina/análogos & derivados , Somatostatina/farmacología
3.
Pharmacol Biochem Behav ; 71(1-2): 251-7, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-11812530

RESUMEN

The study investigates the effects of acute and chronic oral treatment with Hypericum perforatum L. (HP LI 160, 62.5-500 mg/kg) in rats submitted to different anxiety models: the elevated T-maze (for inhibitory avoidance and escape measurements), the light/dark transition, and the cat odor test. These models were selected for their presumed capacity of evidencing specific subtypes of anxiety disorders as recognized in clinical practice. The results showed that acute HP (125 mg/kg) impaired elevated T-maze inhibitory avoidance, an anxiolytic effect, without altering escape performance. Chronic HP (250 mg/kg) enhanced avoidance latencies only in animals that were preexposed to the open arms of the maze. Preexposure shortens escape latency, improving it as an escape index. Differently from the reference drug imipramine (IMP, 15 mg/kg), chronic HP did not impair escape from the open arms of the maze. On the other hand, similarly to IMP, the extract increased the number of transitions between the two compartments in the light/dark transition model. Treatment regimens with HP and IMP did not alter behavioral responses of rats to a cloth impregnated with cat odor. These observations suggest that HP LI 160 exerts anxiolytic-like effects in a specific subset of defensive behaviors, particularly those related to generalized anxiety.


Asunto(s)
Ansiolíticos/administración & dosificación , Ansiedad/tratamiento farmacológico , Hypericum , Extractos Vegetales/administración & dosificación , Animales , Antidepresivos/administración & dosificación , Reacción de Prevención/efectos de los fármacos , Reacción de Prevención/fisiología , Gatos , Oscuridad , Esquema de Medicación , Reacción de Fuga/efectos de los fármacos , Reacción de Fuga/fisiología , Hypericum/química , Luz , Masculino , Fitoterapia/métodos , Ratas , Ratas Wistar
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA